Page last updated: 2024-10-31

clorgyline and Autosomal Dominant Juvenile Parkinson Disease

clorgyline has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahata, K1
Shimazu, S1
Yoneda, F1
Ogawa, M1
Iida, Y1
Saji, H1
Prat, G1
PĂ©rez, V1
Rubi, A1
Casas, M1
Unzeta, M1

Other Studies

2 other studies available for clorgyline and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Effects of monoamine oxidase inhibitors on the diethyldithiocarbamate-induced enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in C57BL/6 mice.
    Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:8

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Body Weight; Cell Death; Clorgyline; Disease

2003
The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:4

    Topics: Adrenergic Agents; Animals; Clorgyline; Corpus Striatum; Dopamine Agents; Dopamine Uptake Inhibitors

2000